-
Starmer faces MPs as pressure grows over Mandelson scandal
-
HRW urges pushback against 'aggressive superpowers'
-
Russia demands Ukraine give in as UAE talks open
-
Gaza civil defence says 17 killed in strikes after Israel says shots wounded officer
-
France's Kante joins Fenerbahce after Erdogan 'support'
-
CK Hutchison launches arbitration over Panama Canal port ruling
-
Stocks mostly rise as traders ignore AI-fuelled sell-off on Wall St
-
Acclaimed Iraqi film explores Saddam Hussein's absurd birthday rituals
-
On rare earth supply, Trump for once seeks allies
-
Ukrainian chasing sumo greatness after meteoric rise
-
Draper to make long-awaited return in Davis Cup qualifier
-
Can Ilia Malinin fulfil his promise at the Winter Olympics?
-
CK Hutchison begins arbitration against Panama over annulled canal contract
-
UNESCO recognition inspires hope in Afghan artist's city
-
Ukraine, Russia, US negotiators gather in Abu Dhabi for war talks
-
WTO must 'reform or die': talks facilitator
-
Doctors hope UK archive can solve under-50s bowel cancer mystery
-
Stocks swing following latest AI-fuelled sell-off on Wall St
-
Demanding Dupont set to fire France in Ireland opener
-
Britain's ex-prince Andrew leaves Windsor home: BBC
-
Coach plots first South Africa World Cup win after Test triumph
-
Spin-heavy Pakistan hit form, but India boycott risks early T20 exit
-
Japan eyes Premier League parity by aligning calendar with Europe
-
Whack-a-mole: US academic fights to purge his AI deepfakes
-
Love in a time of war for journalist and activist in new documentary
-
'Unprecedented mass killing': NGOs battle to quantify Iran crackdown scale
-
Seahawks kid Cooper Kupp seeks new Super Bowl memories
-
Thousands of Venezuelans march to demand Maduro's release
-
AI, manipulated images falsely link some US politicians with Epstein
-
Move on, says Trump as Epstein files trigger probe into British politician
-
Seven Oshyn Experts Honored with 2026 Sitecore Most Valuable Professional Awards
-
Vanderbilt Report: Coeptis Therapeutics Shareholders Approve Transformational Merger: From Biopharma to Dual-Sector Platform
-
Vanderbilt Report: NextTrip's 'Watch It, Book It' Model Gains Momentum as Revenue Surges and Company Acquires 200M-Viewer Travel Platform
-
Vanderbilt Report: Global Clean Energy's AI Division Targets $54 Billion Market Opportunity
-
Transglobal Management Group Achieves Profitability Through Golf Industry Consolidation
-
Vanderbilt Report: RenX Enterprises Builds Technology-Driven Waste-to-Value Platform Through Strategic Asset Monetization and Premium Market Expansion
-
Vanderbilt Report Issues Coverage on Full Alliance Group Inc.
-
The Vanderbilt Report: Argo Graphene Solutions Advances from Concrete Validation to Cold-Climate Asphalt Testing
-
Vanderbilt Report: VisionWave's Strategic Acquisitions Position Company for Defense Market Expansion
-
Pantheon Resources PLC Announces Notice of AGM
-
Arteta backs Arsenal to build on 'magical' place in League Cup final
-
Evil Empire to underdogs: Patriots eye 7th Super Bowl
-
UBS grilled on Capitol Hill over Nazi-era probe
-
Guardiola 'hurt' by suffering caused in global conflicts
-
Marseille do their work early to beat Rennes in French Cup
-
Colombia's Petro, Trump hail talks after bitter rift
-
Trump signs spending bill ending US government shutdown
-
Arsenal sink Chelsea to reach League Cup final
-
Leverkusen sink St Pauli to book spot in German Cup semis
-
'We just need something positive' - Monks' peace walk across US draws large crowds
Medical Care Technologies (OTC PINK:MDCE) Launches Next-Generation AI Validation Program Targeting Clinical-Grade Accuracy
MESA, AZ / ACCESS Newswire / October 6, 2025 / Medical Care Technologies Inc. (OTC Pink:MDCE) announced its plan to benchmark its upcoming AI diagnostic model against the HAM10000 public dermatology dataset to validate its image recognition architecture for detecting various skin lesion types.

The benchmarking process will help evaluate model precision, sensitivity, and specificity relative to peer-reviewed standards. The HAM10000 data will be used under its research license as part of MDCE's ongoing proof-of-concept development.
"We are aligning our performance metrics with globally recognized academic standards," said CEO Marshall Perkins III. "This proactive benchmarking approach underscores our focus on building credible, evidence-backed AI systems for healthcare."
Company Website: www.medicalcaretechnologies.com
Safe Harbor Statement:
Forward-looking statements in this communication reflect current expectations and involve risks that may cause actual results to differ. Factors include data variability, integration challenges, and evolving regulatory guidance. The company assumes no obligation to update such statements.
Contact:
Investor Relations
Medical Care Technologies Inc.
[email protected]
Website: www.mdcestock.com
SOURCE: Medical Care Technologies Inc. (OTC PINK:MDCE)
View the original press release on ACCESS Newswire
O.Gutierrez--AT